SoVarGen
SoVarGen is a biotechnology company that provides drugs for patients with neurological diseases.
Funding reportedLast round: Series B
What company datasets say SoVarGen raised
Funding, as reported
Reported in all35Bin the source's currency
Rounds2
Last roundSeries B
Last round dateSept 2020
Investors listed6
Founders and team
From SoVarGen's own website: 7 on the team.
- Jeong Ho LeeVice President & CSO
- Cheolwon ParkPresident & CEO
- SungJi KimManaging Director / CTO
- Jeong-Wook GhimManaging Director/ Evaluation Center
- Junghyun LeeManaging Director/ Management planning
- Sang Kweon JeonManaging Director/Strategic planning & Mangement support
- Sang Min ParkDirector/ Discovery Center
On 2 portfolio pages
Investors who name them
Each firm lists SoVarGen on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biopharma in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put SoVarGen in front of investors. Or tell us what we have wrong.